Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.
about
Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionLow seroprevalent species D adenovirus vectors as influenza vaccines.The dichotomy of pathogens and allergens in vaccination approachesLong-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotidesPrime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in miceOral adenoviral-based vaccines: historical perspective and future opportunity.Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells.Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.Oral vaccination with an adenovirus-vectored vaccine protects against botulism.Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8⁺ T Lymphocytes in the Female Reproductive Tract.Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunityA single intraduodenal administration of human adenovirus 40 vaccine effectively prevents anaphylactic shock.Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus loadAn efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.Prospects for oral replicating adenovirus-vectored vaccines.In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity.Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination.Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.Firewalls Prevent Systemic Dissemination of Vectors Derived from Human Adenovirus Type 5 and Suppress Production of Transgene-Encoded Antigen in a Murine Model of Oral Vaccination.Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques
P2860
Q27001897-A01E4F2D-BC04-4C24-A4A8-31D023D8469FQ30353263-144A1D6F-4FED-4845-A2A2-B755674430F6Q33909251-05A34B59-C901-46B2-B16A-9EF126F53FA4Q34099837-18B69C90-C970-4016-943C-DD14CC534375Q34258568-242D98DB-7D5E-46BB-9528-3B81B27725C3Q34510430-4CA1D72C-A98F-408D-A594-CDCC26B4AB65Q34746476-6E8C3A8C-794E-4E5E-9F79-F877D254C934Q34990401-250A6CAA-70F0-42DB-BA0F-1778F8671C74Q35099609-8F5162A5-91A4-4DB8-92F2-16E08B01A67FQ36498186-7B53C24A-570A-4919-9C89-332806C74AD1Q36663607-4CE44B82-77B0-4CB7-A12F-6127194A1B71Q36734902-80EE9598-19C3-4067-9093-C82A842E060FQ36735275-5469AA73-8B08-4F50-9124-984CAF29D069Q37247948-755E2CA2-8D51-482B-8D14-0389DB6E9071Q37252311-478982D4-7CBE-45E5-9F19-2935E1F72296Q37552013-CCB357C3-8561-4CFC-BD06-603314A424E2Q37603360-72925E16-5CE8-4A0D-B9F0-C27A979DB5E5Q37693810-CD9A1763-5C6B-4681-9A54-DD766E7F12DCQ37715148-A2D55DDA-0F7C-4A9C-820D-95DD0540DD64Q38109356-AA11A1E8-3329-45F2-A227-9B4F4B0192D0Q38648043-09498BD4-BB77-4AE7-903D-777BB8510E51Q40491287-84E152ED-BA8A-4BE6-A792-12501A6CBFEBQ40757700-B01C1ED4-3965-433F-A91B-F014F5A64D9AQ49167770-CCE9DF6B-17A4-4C07-8D42-7CC6FFD0B248Q58699804-B7674E60-ACAE-4ECE-9D67-3D79C8FA572A
P2860
Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Intramuscular rather than oral ...... + T cell responses in the gut.
@ast
Intramuscular rather than oral ...... + T cell responses in the gut.
@en
type
label
Intramuscular rather than oral ...... + T cell responses in the gut.
@ast
Intramuscular rather than oral ...... + T cell responses in the gut.
@en
prefLabel
Intramuscular rather than oral ...... + T cell responses in the gut.
@ast
Intramuscular rather than oral ...... + T cell responses in the gut.
@en
P2093
P2860
P1433
P1476
Intramuscular rather than oral ...... + T cell responses in the gut.
@en
P2093
P2860
P304
P356
10.1016/J.VACCINE.2006.11.044
P407
P577
2006-12-06T00:00:00Z